Replimune Group Inc’s recent filing unveils that its Director Astley-Sparke Philip unloaded Company’s shares for reported $0.26 million on May 20 ’25. In the deal valued at $8.06 per share,32,279 shares were sold. As a result of this transaction, Astley-Sparke Philip now holds 1,405,071 shares worth roughly $3.95 million.
Then, Xynos Konstantinos sold 7,952 shares, generating $64,093 in total proceeds. Upon selling the shares at $8.06, the Chief Medical Officer now owns 146,933 shares.
Before that, Schwendenman Andrew sold 3,287 shares. Replimune Group Inc shares valued at $26,460 were divested by the Chief Accounting Officer at a price of $8.05 per share. As a result of the transaction, Schwendenman Andrew now holds 68,284 shares, worth roughly $0.19 million.
Wedbush downgraded its Replimune Group Inc [REPL] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who decreased its forecast for the stock in late July from “an Overweight” to “a Neutral”. Leerink Partners also remained covering REPL and has decreased its forecast on July 22, 2025 with a “Market perform” recommendation from previously “an Outperform” rating. JP Morgan revised its rating on July 22, 2025. It rated REPL as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of REPL
On Tuesday, Replimune Group Inc [NASDAQ:REPL] saw its stock fall -77.24% to $2.81. Over the last five days, the stock has lost -77.38%. Replimune Group Inc shares have fallen nearly -72.12% since the year began. Nevertheless, the stocks have fallen -76.84% over the past one year. While a 52-week high of $17.00 was reached on 02/21/25, a 52-week low of $6.44 was recorded on 07/22/25.
Levels Of Support And Resistance For REPL Stock
The 24-hour chart illustrates a support level at 2.47, which if violated will result in even more drops to 2.14. On the upside, there is a resistance level at 3.35. A further resistance level may holdings at 3.89.
How much short interest is there in Replimune Group Inc?
A steep rise in short interest was recorded in Replimune Group Inc stocks on 2025-06-30, growing by 1.39 million shares to a total of 9.9 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-30 was 8.51 million shares. There was a rise of 14.06%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 20, 2025 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating .
